Show Notes
Recently, there has been discussion about ways to potentially put type 2 diabetes into remission. When possible, it could potentially reduce complications and allow people with the condition to reduce or go off medication completely. But, as with most things in diabetes, it’s complicated. And it’s not for everyone.
On this episode, host Krista Lamb speaks with Dr. Harpreet Bajaj who is an endocrinologist and the director of late-phase research at LMC Diabetes. Dr. Bajaj is leading the Diabetes Canada Clinical Practice Guidelines for the Prevention and Treatment of Diabetes in Canada, which recently developed an update that looks at the possibility for type 2 diabetes remission. Read the Guidelines here!
More from Diabetes Canada Podcast
Diabetic ketoacidosis, or DKA, is one of the most feared complications of type 1 diabetes. That’s why researchers are looking for new and innovative ways to increase awareness of what DKA is and how it can be prevented.
How can we change the conversation about diabetes? For Diabetes Awareness Month, that’s a question Diabetes Canada is tackling head on.
How can we change the conversation about diabetes? For Diabetes Awareness Month, that’s a question Diabetes Canada is tackling head on.
Many people are at risk for both diabetes and heart attacks. Millions of people take statin drugs to lower bad cholesterol and reduce the risk of heart attacks. But could these drugs also increase the risk for type 2 diabetes?
As technology in type 1 diabetes becomes more advanced, we are starting to see an increase in personalized therapies. Whether someone is using hybrid closed loop or multiple daily injections, there are options being studied to make living with diabetes easier to manage.